Vera Therapeutics, Inc. (VERA) Debt Components
- 2026-06-30: Notes PayableUSD $75.00M; Long-term DebtUSD $75.23M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $0.00.
- 2026-03-31: Notes PayableUSD $75.00M; Long-term DebtUSD $75.03M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $0.00.
- 2025-12-31: Notes PayableUSD $75.00M; Long-term DebtUSD $74.84M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Notes PayableUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $0.00.
Vera Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Basis Spread on Variable Rate pure | Secured Debt USD | Line of Credit Facility, Remaining Borrowing Capacity USD | Debt Instrument, Interest Rate, Effective Percentage pure | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $75.00M | $75.23M | $0.00 | $0.00 | $34.09M | $40.91M | (m) | $0.00 | $75.00M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $75.00M | $75.03M | $0.00 | $0.00 | $34.09M | $40.91M | (m) | $0.00 | $75.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $75.00M | $74.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $0.00 | $0.00 | $34.09M | $40.91M | (m) | $75.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $75.00M | $74.65M | $0.00 | $0.00 | $0.00 | $34.09M | (m) | $0.00 | $75.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $75.00M | $74.46M | $0.00 | $0.00 | $0.00 | $34.09M | (m) | $0.00 | $75.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 8.25% | (m) | (m) | (m) | (m) |
| 2025-03-31 | $50.00M | $50.91M | $0.00 | (m) | $50.00M | (m) | (m) | $0.00 | $50.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $50.00M | $50.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 8.25% | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $50.00M | $50.47M | (m) | (m) | $50.00M | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $50.00M | $50.26M | (m) | (m) | $50.00M | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $50.00M | $50.07M | (m) | (m) | $50.00M | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) | $-66.00K |
| 2023-12-31 | $50.00M | $49.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $123.00K |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | $50.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $25.00M | $25.04M | (m) | (m) | $25.00M | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $25.00M | $24.96M | (m) | (m) | $25.00M | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $25.00M | $24.89M | (m) | (m) | $25.00M | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $25.00M | $24.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $4.97M | (m) | (m) | (m) | $5.00M | (m) | (m) | $5.00M | (m) | $5.00M | (m) | 11.94% | (m) |
| 2022-06-30 | (m) | $4.95M | (m) | (m) | (m) | $5.00M | (m) | (m) | $5.00M | (m) | $5.00M | $45.00M | 10.53% | (m) |
| 2022-03-31 | (m) | $4.94M | (m) | (m) | (m) | $5.00M | (m) | (m) | $5.00M | (m) | $5.00M | (m) | 9.54% | (m) |
| 2021-12-31 | $5.00M | $4.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | $5.00M | (m) | (m) | (m) | 9.53% | (m) |
| 2020-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |